Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-osteoarthritis effect of Boswellia serrata gum resin extract in monosodium iodoacetate-induced osteoarthritic Sprague-Dawley rats

Monosodium iodoacetate 유도 골관절염 동물모델에서 보스웰리아 검레진 추출물의 항골관절염 효과 연구

  • Jae In Jung (Industry Coupled Cooperation Center for Bio Healthcare Materials, Hallym University) ;
  • Ryong Kim (R&D Division, SRE Service Co. Ltd.) ;
  • Eun Ji Kim (Industry Coupled Cooperation Center for Bio Healthcare Materials, Hallym University)
  • 정재인 (한림대학교 바이오헬스케어소재기업협업센터) ;
  • 김룡 (에스알이서비스(주) 연구개발부) ;
  • 김은지 (한림대학교 바이오헬스케어소재기업협업센터)
  • Received : 2023.04.21
  • Accepted : 2023.05.30
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The aim of this study was to investigate the anti-osteoarthritic effect of the ethanol extract of Boswellia serrata gum resin (FJH-UBS) enriched with keto-β-boswellic acid and 3-O-acetyl-11-keto-β-boswellic acid compared to the conventional Boswellia serrata extract by adding the process of removing oil with hexane, in the monosodium iodoacetate (MIA)-induced osteoarthritis rat model. Methods: Sprague-Dawley (SD) rats were orally administered 0, 40, or 80 mg of FJH-UBS/kg body weight (BW)/day for 5 weeks and injected with MIA intra-articularly into right knee joints on day 15 to induce osteoarthritis. Changes in the knee joint microarchitecture, cartilage degradation, the expression of inflammatory mediators, cytokines, and matrix metalloproteinases (MMPs) in serum and synovia were observed. Results: Oral administration of FJH-UBS (80 mg/kg BW/day) reduced MIA-induced knee swelling and cartilage degradation and increased the expression of type II collagen and aggrecan in articular cartilage. Furthermore, FJH-UBS administration reduced MIA-induced increases in the serum levels of prostaglandin E2, leukotriene B4, interleukin (IL)-1β, IL-6, and MMP-13, and MIA-induced increases in the mRNA expressions of inducible nitric oxide synthase, cyclooxygenase-2, 5-lipoxygenase, IL-1β, IL-6, TNF-α, MMP-2, MMP-9, and MMP-13 in the synovia of knee joints. Conclusion: These results indicate that FJH-UBS exerts its anti-osteoarthritic effects by suppressing the expressions of inflammatory cytokines and MMPs and, thus, cartilage degradation. Furthermore, they suggest that FJH-UBS has potential use as a functional food that improves joint and cartilage health.

본 연구에서는 MIA로 골관절염을 유도한 SD 흰쥐에서 인도산 보스웰리아 검레진을 주정 추출 후, 헥산으로 지방 제거 공정을 추가하여 제조한 보스웰리아 검레진 추출물인 FJH-UBS의 항골관절염 효능을 평가하기 위해 실시하였다. FJH-UBS는 40 또는 80 mg/kg BW/day 용량으로 5주간 경구투여하였고, FJH-UBS를 2주간 투여 후 MIA (3 mg/50 µL/rat)를 무릎 관절강 내에 주사하여 골관절염을 유도하였다. MIA 유도 골관절염 동물모델에서 FJH-UBS는 무릎 관절의 부종을 감소시키고 연골의 분해를 억제하였으며, 연골 내 type II collagen과 aggrecan 발현을 증가시켰다. FJH-UBS (80 mg/kg BW/day)는 혈청 내 PGE2, LTB4, IL-1β, 및 IL-6 함량을 감소시켰고, MMP-13 함량을 감소시켰다. FJH-UBS (80 mg/kg BW/day)는 연골 활막 내 iNOS, COX-2, 5-LOX, IL-1β, IL-6 및 TNF-α 발현을 감소시켰고, MMP-2, MMP-9 및 MMP-13 발현을 감소시켰다. 이 결과는 FJH-UBS가 염증매개물질과 염증성 cytokine의 발현감소를 통해 염증 반응을 억제하고, MMPs의 발현을 억제하여 연골 기질의 분해를 억제함으로서 항골관절염 효능을 나타냄을 의미하며 이는 관절 및 연골 건강 개선 기능성 원료로 FJH-UBS의 활용 가능성을 제시한다.

Keywords

Acknowledgement

We thank FromBIO Co. Ltd. for providing Boswellia serrata gum resin extract (FJH-UBS).

References

  1. Chen D, Shen J, Zhao W, Wang T, Han L, Hamilton JL, et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res 2017; 5(1): 16044.
  2. Oh J, Yi M. [Structural equation modeling on quality of life in older adults with osteoarthritis]. J Korean Acad Nurs 2014; 44(1): 75-85. https://doi.org/10.4040/jkan.2014.44.1.75
  3. Man GS, Mologhianu G. Osteoarthritis pathogenesis - a complex process that involves the entire joint. J Med Life 2014; 7(1): 37-41.
  4. Sirse M. Effect of dietary polyphenols on osteoarthritis-molecular mechanisms. Life (Basel) 2022; 12(3): 436.
  5. Nam DE, Kim OK, Shim TJ, Kim JH, Lee J. Effect of Boswellia serrata extracts on degenerative osteoarthritis in vitro and in vivo models. J Korean Soc Food Sci Nutr. 2014; 43(5): 631-940. https://doi.org/10.3746/jkfn.2014.43.5.631
  6. Fibel KH, Hillstrom HJ, Halpern BC. State-of-the-art management of knee osteoarthritis. World J Clin Cases 2015; 3(2): 89-101. https://doi.org/10.12998/wjcc.v3.i2.89
  7. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011; 342: c7086.
  8. Mannino G, Occhipinti A, Maffei ME. Quantitative determination of 3-O-acetyl-11-keto-β-boswellic acid (AKBA) and other boswellic acids in Boswellia sacra Flueck (syn. B. carteri Birdw) and Boswellia serrata Roxb. Molecules 2016; 21(10): 1329.
  9. Zhang J, Zhao J, Sun Y, Liang Y, Zhao J, Zou H, et al. GR-mediated anti-inflammation of α-boswellic acid: insights from in vitro and in silico studies. Food Chem Toxicol 2021; 155: 112379.
  10. Zimmermann-Klemd AM, Reinhardt JK, Nilsu T, Morath A, Falanga CM, Schamel WW, et al. Boswellia carteri extract and 3-O-acetyl-alpha-boswellic acid suppress T cell function. Fitoterapia 2020; 146: 104694.
  11. Bharat KT, Manhas NS, Gutcho J, Lin J, Bhattacharyya S, Kounang R. Ingredients of a natural oral nutritional supplement and their role in the treatment of osteoarthritis. Clin Med Insights Arthritis Musculoskelet Disord 2022; 15: 11795441211063365.
  12. Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, et al. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford) 2013; 52(8): 1408-1417. https://doi.org/10.1093/rheumatology/kes414
  13. Lee J, Jeong I, Kim GW, Son T, Kim Y, Jun W, et al. Standardized ethanolic extracts of Boswellia serrata ameliorate symptoms of osteoarthritis by direct effects on chondrocytes. J Food Nutr Res 2021; 9(12): 614-625. https://doi.org/10.12691/jfnr-9-12-1
  14. Majeed M, Majeed S, Narayanan NK, Nagabhushanam K. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother Res 2019; 33(5): 1457-1468. https://doi.org/10.1002/ptr.6338
  15. Notarnicola A, Maccagnano G, Moretti L, Pesce V, Tafuri S, Fiore A, et al. Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial. Int J Immunopathol Pharmacol 2016; 29(1): 140-146. https://doi.org/10.1177/0394632015622215
  16. Borner F, Werner M, Ertelt J, Meins J, Abdel-Tawab M, Werz O. Analysis of boswellic acid contents and related pharmacological activities of frankincense-based remedies that modulate inflammation. Pharmaceuticals (Basel) 2021; 14(7): 660.
  17. Meins J, Artaria C, Riva A, Morazzoni P, Schubert-Zsilavecz M, Abdel-Tawab M. Survey on the quality of the top-selling european and american botanical dietary supplements containing boswellic acids. Planta Med 2016; 82(6): 573-579. https://doi.org/10.1055/s-0042-103497
  18. Jung JI, Lee HS, Kim R, Kim EJ. Anti-osteoarthritis effect of enriched Boswellia serrata gum resin extract in SW1353 chondrocytes. J Korean Soc Food Sci Nutr 2023; 52(5): 460-472. https://doi.org/10.3746/jkfn.2023.52.5.460
  19. Lim SM, Lee HS, Jung JI, Kim SM, Kim NY, Seo TS, et al. Cyanidin-3-O-galactoside-enriched Aronia melanocarpa extract attenuates weight gain and adipogenic pathways in high-fat diet-induced obese C57BL/6 mice. Nutrients 2019; 11(5): 11.
  20. Wojdasiewicz P, Poniatowski LA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm 2014; 2014: 561459.
  21. Sheu SY, Ho SR, Sun JS, Chen CY, Ke CJ. Arthropod steroid hormone (20-Hydroxyecdysone) suppresses IL-1β-induced catabolic gene expression in cartilage. BMC Complement Altern Med 2015; 15(1): 1.
  22. Lin Z, Wu D, Huang L, Jiang C, Pan T, Kang X, et al. Nobiletin inhibits IL-1β-induced inflammation in chondrocytes via suppression of NF-κB signaling and attenuates osteoarthritis in mice. Front Pharmacol 2019; 10: 570.
  23. Zhang M, Zhang R, Zheng T, Chen Z, Ji G, Peng F, et al. Xanthohumol attenuated inflammation and ECM degradation by mediating HO-1/C/EBPβ pathway in osteoarthritis chondrocytes. Front Pharmacol 2021; 12: 680585.
  24. Amalinei C, Caruntu ID, Giusca SE, Balan RA. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol 2010; 51(2): 215-228.
  25. Jenei-Lanzl Z, Meurer A, Zaucke F. Interleukin-1β signaling in osteoarthritis - chondrocytes in focus. Cell Signal 2019; 53: 212-223. https://doi.org/10.1016/j.cellsig.2018.10.005
  26. Liu CC, Zhang Y, Dai BL, Ma YJ, Zhang Q, Wang Y, et al. Chlorogenic acid prevents inflammatory responses in IL-1β-stimulated human SW-1353 chondrocytes, a model for osteoarthritis. Mol Med Rep 2017; 16(2): 1369-1375. https://doi.org/10.3892/mmr.2017.6698
  27. Zeng L, Rong XF, Li RH, Wu XY. Icariin inhibits MMP-1, MMP-3 and MMP-13 expression through MAPK pathways in IL-1β-stimulated SW1353 chondrosarcoma cells. Mol Med Rep 2017; 15(5): 2853-2858. https://doi.org/10.3892/mmr.2017.6312
  28. Yamamoto K, Okano H, Miyagawa W, Visse R, Shitomi Y, Santamaria S, et al. MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1. Matrix Biol 2016; 56: 57-73. https://doi.org/10.1016/j.matbio.2016.03.007
  29. Zhang H, Ji L, Yang Y, Wei Y, Zhang X, Gang Y, et al. The therapeutic effects of treadmill exercise on osteoarthritis in rats by inhibiting the HDAC3/NF-kappaB pathway in vivo and in vitro. Front Physiol 2019; 10: 1060.
  30. Sondergaard BC, Schultz N, Madsen SH, Bay-Jensen AC, Kassem M, Karsdal MA. MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation--divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation. Osteoarthritis Cartilage 2010; 18(3): 279-288. https://doi.org/10.1016/j.joca.2009.11.005
  31. Saklatvala J. Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis. Curr Drug Targets 2007; 8(2): 305-313. https://doi.org/10.2174/138945007779940115
  32. Xu F, Zhao LJ, Liao T, Li ZC, Wang LL, Lin PY, et al. Ononin ameliorates inflammation and cartilage degradation in rat chondrocytes with IL-1β-induced osteoarthritis by downregulating the MAPK and NF-κB pathways. BMC Complement Med Ther 2022; 22(1): 25.
  33. Mariano A, Bigioni I, Misiti F, Fattorini L, Scotto D'Abusco A, Rodio A. The nutraceuticals as modern key to achieve erythrocyte oxidative stress fighting in osteoarthritis. Curr Issues Mol Biol 2022; 44(8): 3481-3495. https://doi.org/10.3390/cimb44080240
  34. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet 2011; 50(6): 349-369. https://doi.org/10.2165/11586800-000000000-00000